A team of researchers in Kansai is set to begin clinical trials next month to develop medicine to help grow teeth.

The researchers, including from Kitano Hospital and Kyoto University Hospital, will conduct trials for teething medicine, aimed at treating people with congenital anodontia who are born with few teeth.

To check its safety, the experimental drug will first be administered to adult men who have lost back teeth, before it is tested on children with congenital anodontia. The team aims to put the treatment into practical use in around 2030.

  • AwesomeLowlander@sh.itjust.worksEnglish
    0·
    3 months ago

    Given the average quality of science reporting and the lack of actual journal articles, it might be the same thing with a misunderstanding in either the earlier article or this one.

    • orrk@lemmy.worldEnglish
      0·
      3 months ago

      science reporting is awesome, I love when people start pushing random BS because they decided they needed to “dumb it down” because they themselves were too dumb to get it in the first place

    • ColeSloth@discuss.tchncs.deEnglish
      0·
      3 months ago

      Oh man. It seems the only misunderstanding is that no one else in here understands the article or what congenital anodontia actually is. So what I had initially stated, and per this article, it won’t help 99% of people.

      • AwesomeLowlander@sh.itjust.worksEnglish
        0·
        3 months ago

        The treatment may be applied in the future to people who have permanently lost teeth due to cavities and other problems.

        How do we not understand the article? If the article is full of bull, that’s another story